Order Total (1 Item Items):
Shipping Destination:
Gerda Egger (11 results)
Skip to main search results
Search filters
Product Type
- All Product Types
- Books (11)
- Magazines & Periodicals (No further results match this refinement)
- Comics (No further results match this refinement)
- Sheet Music (No further results match this refinement)
- Art, Prints & Posters (No further results match this refinement)
- Photographs (No further results match this refinement)
- Maps (No further results match this refinement)
- Manuscripts & Paper Collectibles (No further results match this refinement)
Condition Learn more
- New (9)
- As New, Fine or Near Fine (2)
- Very Good or Good (No further results match this refinement)
- Fair or Poor (No further results match this refinement)
- As Described (No further results match this refinement)
Binding
Collectible Attributes
- First Edition (No further results match this refinement)
- Signed (No further results match this refinement)
- Dust Jacket (No further results match this refinement)
- Seller-Supplied Images (3)
- Not Print on Demand (8)
Language (1)
Price
- Any Price
- Under US$ 25 (No further results match this refinement)
- US$ 25 to US$ 50
- Over US$ 50
Free Shipping
- Free Shipping to U.S.A. (No further results match this refinement)
Seller Location
Seller Rating
-
Condition: As New. Unread book in perfect condition.
-
Condition: New.
-
US$ 30.91
US$ 20.00 shipping
Ships from United Kingdom to U.S.A.Quantity: 6 available
Add to basketCondition: New.
-
US$ 33.74
US$ 20.00 shipping
Ships from United Kingdom to U.S.A.Quantity: 6 available
Add to basketCondition: As New. Unread book in perfect condition.
-
Fav Pieces
Language: English
Published by Vfmk Verlag für moderne Kunst GmbH, 2026
ISBN 10: 399153214X ISBN 13: 9783991532149
Condition: New.
-
Drug Discovery in Cancer Epigenetics (Translational Epigenetics Series)
Book 3 of 39: Translational EpigeneticsLanguage: English
Published by Academic Press 2016-02-05, 2016
ISBN 10: 0128022086 ISBN 13: 9780128022085
US$ 139.26
US$ 20.66 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketHardcover. Condition: New.
-
US$ 159.09
US$ 20.00 shipping
Ships from United Kingdom to U.S.A.Quantity: 2 available
Add to basketHardcover. Condition: Brand New. 1st edition. 498 pages. 9.50x8.00x1.00 inches. In Stock.
-
Drug Discovery in Cancer Epigenetics
Book 3 of 39: Translational EpigeneticsLanguage: English
Published by Elsevier Science Publishing Co Inc, 2015
ISBN 10: 0128022086 ISBN 13: 9780128022085
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Seller rating 5 out of 5 stars
US$ 172.65
US$ 30.34 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketHardback. Condition: New. New copy - Usually dispatched within 4 working days.
-
Condition: new. Questo è un articolo print on demand.
-
Drug Discovery in Cancer Epigenetics
Book 3 of 39: Translational EpigeneticsLanguage: English
Published by Elsevier Science Dez 2015, 2015
ISBN 10: 0128022086 ISBN 13: 9780128022085
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Seller rating 5 out of 5 stars
Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic. 498 pp. Englisch.
-
Buch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Drug Discovery in Cancer Epigenetics is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic.
